Abrdn Life Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Abrdn Life Sciences Investors (NYSE:HQL – Get Free Report) major shareholder Saba Capital Management, L.P. bought 9,704 shares of the firm’s stock in a transaction dated Monday, June 10th. The stock was bought at an average cost of $13.71 per share, with a total value of $133,041.84. Following the transaction, the insider now directly owns […]

Abrdn Life Sciences Investors (NYSE:HQL – Get Free Report) major shareholder Saba Capital Management, L.P. bought 81,738 shares of Abrdn Life Sciences Investors stock in a transaction dated Thursday, April 18th. The shares were acquired at an average price of $12.80 per share, with a total value of $1,046,246.40. Following the completion of the purchase, […]